DJ-1 protein regulates CD3+ T cell migration via overexpression of CXCR4 receptor

Atherosclerosis

Volumn 235, Issue 2, 2014, Pages 503-509

  Jung, Seung Hyo ^a   Won, Kyung Jong ^a   Lee, Kang Pa ^a   Lee, Dong Hyun ^a   Yu, Suyeol ^a   Lee, Dong Youb ^a   Seo, Eun Hye ^a   Kang, Hyun ^a   Park, Eun Seok ^a,b   Kim, Hyun Joong ^a   Lee, Seung Hyun ^a   Kim, Bokyung ^a  

^a Konkuk University School of Medicine   (South Korea)

^b Kyungbok University   (South Korea)

Author keywords

Atherosclerotic plaque; CD3+ T cell migration; CXCR4 receptor; DJ 1; Stromal cell derived factor 1

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; CD3 ANTIGEN; CHEMOKINE RECEPTOR CXCR4; DJ 1 PROTEIN; GAMMA INTERFERON; INTERLEUKIN 17; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; STROMAL CELL DERIVED FACTOR 1; DJ-1 PROTEIN, MOUSE; ONCOPROTEIN; PEROXIREDOXIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; ATHEROSCLEROSIS; CAROTID ARTERY LIGATION; CD3+ T LYMPHOCYTE; CELL FUNCTION; CELL MIGRATION; CELL STIMULATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; GENE INACTIVATION; MALE; MOUSE; NEOINTIMA; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; T LYMPHOCYTE SUBPOPULATION; TH1 CELL; TH17 CELL; WILD TYPE; ANIMAL; BIOSYNTHESIS; CELL MOTION; DRUG EFFECTS; GENETICS; KNOCKOUT MOUSE; METABOLISM; PHOSPHORYLATION; PHYSIOLOGY; T LYMPHOCYTE;

ANIMALS; ANTIGENS, CD3; CELL MOVEMENT; CHEMOKINE CXCL12; MALE; MICE, KNOCKOUT; MITOGEN-ACTIVATED PROTEIN KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE 3; NEOINTIMA; ONCOGENE PROTEINS; PEROXIREDOXINS; PHOSPHORYLATION; RECEPTORS, CXCR4; T-LYMPHOCYTES;

EID: 84914102053     PISSN: 00219150     EISSN: 18791484     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2014.05.955     Document Type: Article

References (42)

1. Bosch J.A., Berntson G.G., Cacioppo J.T., Dhabhar F.S., Marucha P.T. Acute stress evokes selective mobilization of T cells that differ in chemokine receptor expression: a potential pathway linking immunologic reactivity to cardiovascular disease. Brain Behav Immun 2003, 17:251-259.
2. Chi Z., Melendez A.J. Role of cell adhesion molecules and immune-cell migration in the initiation, onset and development of atherosclerosis. Cell Adh Migr 2007, 1:171-175.
3. Bonecchi R., Bianchi G., Bordignon P.P., D'Ambrosio D., Lang R., Borsatti A., et al. Differential expression of chemokine receptors and chemotactic responsiveness of type 1 T helper cells (Th1s) and Th2s. JExp Med 1998, 187:129-134.
4. Bleul C.C., Fuhlbrigge R.C., Casasnovas J.M., Aiuti A., Springer T.A. Ahighly efficacious lymphocyte chemoattractant, stromal cell-derived factor 1 (SDF-1). JExp Med 1996, 184:1101-1109.
5. Lataillade J.J., Clay D., Dupuy C., Rigal S., Jasmin C., Bourin P., et al. Chemokine SDF-1 enhances circulating CD34+ cell proliferation in synergy with cytokines: possible role in progenitor survival. Blood 2000, 95:756-768.
6. Zhou Y., Larsen P.H., Hao C., Yong V.W. CXCR4 is a major chemokine receptor on glioma cells and mediates their survival. JBiol Chem 2002, 277:49481-49487.
7. Herbein G., Mahlknecht U., Batliwalla F., Gregersen P., Pappas T., Butler J., et al. Apoptosis of CD8+ T cells is mediated by macrophages through interaction of HIV gp120 with chemokine receptor CXCR4. Nature 1998, 395:189-194.
8. Hesselgesser J., Taub D., Baskar P., Greenberg M., Hoxie J., Kolson D.L., et al. Neuronal apoptosis induced by HIV-1 gp120 and the chemokine SDF-1 alpha is mediated by the chemokine receptor CXCR4. Curr Biol 1998, 8:595-598.
9. Berndt C., Mopps B., Angermuller S., Gierschik P., Krammer P.H. CXCR4 and CD4 mediate a rapid CD95-independent cell death in CD4+ T cells. Proc Natl Acad Sci USA 1998, 95:12556-12561.
10. Vlahakis S.R., Villasis-Keever A., Gomez T., Vanegas M., Vlahakis N., Paya C.V. Gprotein-coupled chemokine receptors induce both survival and apoptotic signaling pathways. JImmunol 2002, 169:5546-5554.
11. Abi-Younes S., Sauty A., Mach F., Sukhova G.K., Libby P., Luster A.D. The stromal cell-derived factor-1 chemokine is a potent platelet agonist highly expressed in atherosclerotic plaques. Circulation Res 2000, 86:131-138.
12. Damas J.K., Waehre T., Yndestad A., Ueland T., Muller F., Eiken H.G., et al. Stromal cell-derived factor-1 alpha in unstable angina: potential antiinflammatory and matrix-stabilizing effects. Circulation 2002, 106:36-42.
13. Han C.I., Campbell G.R., Campbell J.H. Circulating bone marrow cells can contribute to neointimal formation. JVasc Res 2001, 38:113-119.
14. Sata M., Saiura A., Kunisato A., Tojo A., Okada S., Tokuhisa T., et al. Hematopoietic stem cells differentiate into vascular cells that participate in the pathogenesis of atherosclerosis. Nat Med 2002, 8:403-409.
15. Schober A., Knarren S., Lietz M., Lin E.A., Weber C. Crucial role of stromal cell-derived factor-1 alpha in neointima formation after vascular injury in apolipoprotein E-deficient mice. Circulation 2003, 108:2491-2497.
16. Zernecke A., Weber C. Inflammatory mediators in atherosclerotic vascular disease. Basic Res Cardiol 2005, 100:93-101.
17. Ait-Oufella H., Taleb S., Mallat Z., Tedgui A. Recent advances on the role of cytokines in atherosclerosis. Arterioscler Thromb Vasc Biol 2011, 31:969-979.
18. Gupta S., Pablo A.M., Jiang X., Wang N., Tall A.R., Schindler C. IFN-gamma potentiates atherosclerosis in ApoE knock-out mice. JClin Invest 1997, 99:2752-2761.
19. Tellides G., Tereb D.A., Kirkiles-Smith N.C., Kim R.W., Wilson J.H., Schechner J.S., et al. Interferon-gamma elicits arteriosclerosis in the absence of leukocytes. Nature 2000, 403:207-211.
20. Takatori H., Kanno Y., Watford W.T., Tato C.M., Weiss G., Ivanov, et al. Lymphoid tissue inducer-like cells are an innate source of IL-17 and IL-22. JExp Med 2009, 206:35-41.
21. Eid R.E., Rao D.A., Zhou J., Lo S.F., Ranjbaran H., Gallo A., et al. Interleukin-17 and interferon-gamma are produced concomitantly by human coronary artery-infiltrating T cells and act synergistically on vascular smooth muscle cells. Circulation 2009, 119:1424-1432.
22. Andres-Mateos E., Perier C., Zhang L., Blanchard-Fillion B., Greco T.M., Thomas B., et al. DJ-1 gene deletion reveals that DJ-1 is an atypical peroxiredoxin-like peroxidase. Proc Natl Acad Sci USA 2007, 104:14807-14812.
23. Takahashi-Niki K., Niki T., Taira T., Iguchi-Ariga S.M., Ariga H. Reduced anti-oxidative stress activities of DJ-1 mutants found in Parkinson's disease patients. Biochem Biophys Res Commun 2004, 320:389-397.
24. Marcondes A.M., Li X., Gooley T.A., Milless B., Deeg H.J. Identification of DJ-1/PARK-7 as a determinant of stroma-dependent and TNF-alpha-induced apoptosis in MDS using mass spectrometry and phosphopeptide analysis. Blood 2010, 115:1993-2002.
25. Lee C.K., Park H.J., So H.H., Kim H.J., Lee K.S., Choi W.S., et al. Proteomic profiling and identification of cofilin responding to oxidative stress in vascular smooth muscle. Proteomics 2006, 6:6455-6475.
26. Kim D.K., Kim H.S., Kim A.R., Kim J.H., Kim B., Noh G., et al. DJ-1 regulates mast cell activation and IgE-mediated allergic responses. JAllergy Clin Immunol 2013, 131:1653-1662.
27. Won K.J., Jung S.H., Lee C.K., Na H.R., Lee K.P., Lee D.Y., et al. DJ-1/park7 protects against neointimal formation via the inhibition of vascular smooth muscle cell growth. Cardiovasc Res 2013, 97:553-561.
28. Cuevas S., Zhang Y., Yang Y., Escano C., Asico L., Jones J.E., et al. Role of renal DJ-1 in the pathogenesis of hypertension associated with increased reactive oxygen species production. Hypertension 2012, 59:446-452.
29. Moon E.Y., Noh Y.W., Han Y.H., Kim S.U., Kim J.M., Yu D.Y., et al. Tlymphocytes and dendritic cells are activated by the deletion of peroxiredoxin II (Prx II) gene. Immunol Letters 2006, 102:184-190.
30. 2 and CD3 cross-linking. JBiol Chem 1998, 273:10771-10776.
31. Busillo J.M., Benovic J.L. Regulation of CXCR4 signaling. Biochim Biophys Acta 2007, 1768:952-963.
32. Kumar R., Tripathi V., Ahmad M., Nath N., Mir R.A., Chauhan S.S., et al. CXCR7 mediated gialpha independent activation of ERK and Akt promotes cell survival and chemotaxis in T cells. Cell Immunol 2012, 272:230-241.
33. Laudanna C., Kim J.Y., Constantin G., Butcher E. Rapid leukocyte integrin activation by chemokines. Immunol Rev 2002, 186:37-46.
34. Galan J.A., Paris L.L., Zhang H.J., Adler J., Geahlen R.L., Tao W.A. Proteomic studies of Syk-interacting proteins using a novel amine-specific isotope tag and GFP nanotrap. JAm Soc Mass Spectrom 2011, 22:319-328.
35. Chetram M.A., Don-Salu-Hewage A.S., Hinton C.V. ROS enhances CXCR4-mediated functions through inactivation of PTEN in prostate cancer cells. Biochem Biophys Res Commun 2011, 410:195-200.
36. Tesio M., Golan K., Corso S., Giordano S., Schajnovitz A., Vagima Y., et al. Enhanced c-Met activity promotes G-CSF-induced mobilization of hematopoietic progenitor cells via ROS signaling. Blood 2011, 117:419-428.
37. Profumo E., Buttari B., Tosti M.E., Tagliani A., Capoano R., D'Amati G., et al. Plaque-infiltrating T lymphocytes in patients with carotid atherosclerosis: an insight into the cellular mechanisms associated to plaque destabilization. JCardiovasc Surg (Torino) 2013, 54:349-357.
38. Ticchioni M., Charvet C., Noraz N., Lamy L., Steinberg M., Bernard A., et al. Signaling through ZAP-70 is required for CXCL12-mediated T-cell transendothelial migration. Blood 2002, 99:3111-3118.
39. Chen Y.C., Tien Y.J., Chen C.H., Beltran F.N., Amor E.C., Wang R.J., et al. Morus alba and active compound oxyresveratrol exert anti-inflammatory activity via inhibition of leukocyte migration involving MEK/ERK signaling. BMC Complement Altern Med 2013, 13:45.
40. Tedgui A., Mallat Z. Cytokines in atherosclerosis: pathogenic and regulatory pathways. Physiol Rev 2006, 86:515-581.
41. Madhur M.S., Funt S.A., Li L., Vinh A., Chen W., Lob H.E., et al. Role of interleukin 17 in inflammation, atherosclerosis, and vascular function in apolipoproteine-deficient mice. Arterioscler Thromb Vasc Biol 2011, 31:1565-1572.
42. Hui D.Y. Intimal hyperplasia in murine models. Curr Drug Targets 2008, 9:251-260.